Evidence map›Paper›PMID 22895629›Full record

ArticleOncology reports2012

Anti-angiogenic and antitumor activities of Huaier aqueous extract.

Xiaolong Wang, Ning Zhang, Qiang Huo, Qifeng Yang

4 registry-linked trialsAbstract read
In one paragraph

Article in Oncology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02615457 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

Huaier Granule in Treating Women With Triple Negative Breast Cancer

TypeinterventionalSponsorShandong UniversityRan2015Enrolled300ConditionsTriple Negative Breast CancerArmsHuaier Granule
NCT02627248 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

TypeinterventionalSponsorShandong UniversityRan2015 to 2025Enrolled200ConditionsBreast CancerArmsHuaier Granule, Epirubicin, Docetaxel, Cyclophosphamide
NCT02785146 phase3unknown statusnot on this mapstarted 2016, after this paper: background citation

Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer

TypeinterventionalSponsorSixth Affiliated Hospital, Sun Yat-sen UniversityRan2016 to 2018Enrolled230ConditionsColorectal CancerArmsHuaier Granule, Oxaliplatin, Calcium folinate, 5-fluorouracil
NCT02796820 phase3unknown statusnot on this mapstarted 2016, after this paper: background citation

Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery

TypeinterventionalSponsorSixth Affiliated Hospital, Sun Yat-sen UniversityRan2016 to 2018Enrolled230ConditionsColorectal CancerArmsHuaier Granule
3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Efficacy of Huaier granule in patients with breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Article
  18. Article
  19. Article
  20. Cancer management and research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaolong WangDepartment of Breast Surgery, Qilu Hospital, Shandong Univeristy School of Medicine, Jinan, Shandong 250012, P.R. China.
Ning Zhang
Qiang Huo
Qifeng Yang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese medicine, a rich source of potent cancer chemopreventive agents, is attracting increasing attention worldwide. Recently, the anticancer activity of Trametes robiniophila Μurr. (Huaier) has been widely investigated. However, the mechanisms are not yet fully understood. This study aimed to elucidate the inhibitory effect of Huaier extract on angiogenesis and tumor growth. Incubation with Huaier extract inhibited the proliferation of human umbilical vein endothelial cells (HUVECs) and mouse mammary tumor cells (4T1). In addition, treatment with Huaier extract decreased the motility and tube formation of HUVECs in a dose-dependent manner in vitro. As determined by western blot analysis, Huaier extract dose-dependently decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK), transcription factor p65, c-Jun N-terminal kinase (JNK), signal transducer and activator of transcription 3 (STAT3) and the expression of vascular endothelial growth factor (VEGF). In ex vivo experiments, new vessel growth was suppressed as shown by chick embryo chorioallantoic membrane (CAM) and rat aortic ring assays in the presence of Huaier extract. To further evaluate the inhibitory effect, 4T1 cells were injected subcutaneously into BALB/c mice. The administration of Huaier extract suppressed tumor volume, decreased microvessel density and induced apoptosis. These data suggest that Huaier extract may serve as a potent anti-angiogenic and antitumor agent.

Indexed as

Medicine, Chinese TraditionalAngiogenesis InhibitorsAnimalsAntineoplastic Agents, PhytogenicApoptosisCell Cycle CheckpointsCell MovementChick EmbryoChorioallantoic MembraneDose-Response Relationship, DrugDrug Screening Assays, AntitumorEndothelium, VascularFemaleHumansHuman Umbilical Vein Endothelial CellsIn Vitro TechniquesAngiogenesis InhibitorsAntineoplastic Agents, PhytogenicPlant Extracts

Identifiers

PMID22895629
PMCPMC3583466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.